Concepedia

Noortje van Gils

NV

Statistics

Publications

11

Citations

838

H-Index

11

Active since

2015

Affiliations

Leiden University(Current)

Amsterdam University Medical Centers

Amsterdam UMC Location Vrije Universiteit Amsterdam

Cancer Center Amsterdam

Università Campus Bio-Medico

Noortje van Gils is an author at Leiden University specializing in medicine, pharmacology, and oncology.

Publications per year

2015–2023

11

Publications

11

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity

Marjolein Soethoudt, Uwe Grether, Jürgen Fingerle et al. · Nature Communications · 2017 · 351 citations · Full text

, , +11

Uncoupling DNA damage from chromatin damage to detoxify doxorubicin

Xiaohang Qiao, Sabina Y. van der Zanden, Dennis P. A. Wander et al. · Proceedings of the National Academy of Sciences · 2020 · 168 citations · Full text

, , +17

Structural basis of ligand interaction with atypical chemokine receptor 3

Martin Gustavsson, Liwen Wang, Noortje van Gils et al. · Nature Communications · 2017 · 110 citations · Full text

, , +17

The novel, orally available and peripherally restricted selective cannabinoid CB<sub>2</sub> receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

Partha Mukhopadhyay, Marc P. Baggelaar, Katalin Erdélyi et al. · British Journal of Pharmacology · 2015 · 84 citations · Full text

, , +10

The Novel Oral BET-CBP/p300 Dual Inhibitor NEO2734 Is Highly Effective in Eradicating Acute Myeloid Leukemia Blasts and Stem/Progenitor Cells

Noortje van Gils, Tania Martiáñez Canales, Eline Vermue et al. · HemaSphere · 2021 · 33 citations · Full text

, , +17

1–5 of 11